FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003923132> ?p ?o ?g. }

• W2003923132 endingPage "1742" @default.
• W2003923132 startingPage "1742" @default.
• W2003923132 abstract "Several lines of evidence have implicated high levels of advanced glycation endproducts (AGEs) in diabetes. Pancreas impairment caused by AGEs has been found in recent studies. Monascin (MS) and monacolin K (MK) are active compounds identified from Monascus-fermented products, which have been reported to inhibit inflammation and improve insulin resistance. In order to confirm the protective effects of MS and MK on pancreatic function, BALB/c mice were treated with AGEs via intraperitoneal injection for 22 weeks to induce hyperglycemia, and the pancreas-protecting mechanism of MS and MK from AGE-induced damage was investigated. We found that the expression of pancreatic and duodenal homeobox-1 (PDX-1) and glucose transporter 2 (GLUT2) was recovered by MS or MK administration to AGE-treated mice. In addition, MS strongly improved performance in the oral glucose tolerance test (OGTT) and the insulin tolerance test (ITT), suggesting that MS sensitized to insulin in AGE-treated mice. Both MS and MK elevated pancreatic insulin expression when compared to the AGE-treated group, suggesting that MS and MK attenuated AGE-induced pancreatic dysfunction. Histopathology studies showed that intraperitoneal injection of AGEs did not result in pancreas damage. These findings confirm that the potential mechanism of AGEs on pancreatic dysfunction involves the induction of inflammation and the suppression of PDX-1 and GLUT2 expression. Taken together, MS and MK may be developed as an anti-diabetic agent in the future." @default.
• W2003923132 created "2016-06-24" @default.
• W2003923132 creator A5001168014 @default.
• W2003923132 creator A5008388056 @default.
• W2003923132 creator A5025628943 @default.
• W2003923132 creator A5063899896 @default.
• W2003923132 creator A5064577387 @default.
• W2003923132 date "2013-01-01" @default.
• W2003923132 modified "2023-10-16" @default.
• W2003923132 title "Monacolin K and monascin attenuated pancreas impairment and hyperglycemia induced by advanced glycation endproducts in BALB/c mice" @default.
• W2003923132 cites W1531479789 @default.
• W2003923132 cites W1570936570 @default.
• W2003923132 cites W1966407301 @default.
• W2003923132 cites W1972012269 @default.
• W2003923132 cites W1973940300 @default.
• W2003923132 cites W1997105226 @default.
• W2003923132 cites W1998900256 @default.
• W2003923132 cites W2001087462 @default.
• W2003923132 cites W2002065167 @default.
• W2003923132 cites W2003535661 @default.
• W2003923132 cites W2003984928 @default.
• W2003923132 cites W2010036181 @default.
• W2003923132 cites W2013804650 @default.
• W2003923132 cites W2019570781 @default.
• W2003923132 cites W2044636787 @default.
• W2003923132 cites W2048871706 @default.
• W2003923132 cites W2052439818 @default.
• W2003923132 cites W2067947009 @default.
• W2003923132 cites W2068135486 @default.
• W2003923132 cites W2068331074 @default.
• W2003923132 cites W2081193499 @default.
• W2003923132 cites W2082187899 @default.
• W2003923132 cites W2090115750 @default.
• W2003923132 cites W2093478842 @default.
• W2003923132 cites W2093974114 @default.
• W2003923132 cites W2097768916 @default.
• W2003923132 cites W2125023371 @default.
• W2003923132 cites W2132763840 @default.
• W2003923132 cites W2138689678 @default.
• W2003923132 cites W2140635558 @default.
• W2003923132 cites W2145306055 @default.
• W2003923132 cites W2150695169 @default.
• W2003923132 doi "https://doi.org/10.1039/c3fo60268k" @default.
• W2003923132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24154804" @default.
• W2003923132 hasPublicationYear "2013" @default.
• W2003923132 type Work @default.
• W2003923132 sameAs 2003923132 @default.
• W2003923132 citedByCount "15" @default.
• W2003923132 countsByYear W20039231322013 @default.
• W2003923132 countsByYear W20039231322015 @default.
• W2003923132 countsByYear W20039231322016 @default.
• W2003923132 countsByYear W20039231322017 @default.
• W2003923132 countsByYear W20039231322018 @default.
• W2003923132 countsByYear W20039231322020 @default.
• W2003923132 countsByYear W20039231322021 @default.
• W2003923132 countsByYear W20039231322022 @default.
• W2003923132 countsByYear W20039231322023 @default.
• W2003923132 crossrefType "journal-article" @default.
• W2003923132 hasAuthorship W2003923132A5001168014 @default.
• W2003923132 hasAuthorship W2003923132A5008388056 @default.
• W2003923132 hasAuthorship W2003923132A5025628943 @default.
• W2003923132 hasAuthorship W2003923132A5063899896 @default.
• W2003923132 hasAuthorship W2003923132A5064577387 @default.
• W2003923132 hasConcept C126322002 @default.
• W2003923132 hasConcept C134018914 @default.
• W2003923132 hasConcept C147990577 @default.
• W2003923132 hasConcept C161573976 @default.
• W2003923132 hasConcept C2776914184 @default.
• W2003923132 hasConcept C2777391703 @default.
• W2003923132 hasConcept C2777901630 @default.
• W2003923132 hasConcept C2778764654 @default.
• W2003923132 hasConcept C2779113265 @default.
• W2003923132 hasConcept C2779306644 @default.
• W2003923132 hasConcept C2780159080 @default.
• W2003923132 hasConcept C2780609358 @default.
• W2003923132 hasConcept C2780833929 @default.
• W2003923132 hasConcept C3017594256 @default.
• W2003923132 hasConcept C555293320 @default.
• W2003923132 hasConcept C71924100 @default.
• W2003923132 hasConceptScore W2003923132C126322002 @default.
• W2003923132 hasConceptScore W2003923132C134018914 @default.
• W2003923132 hasConceptScore W2003923132C147990577 @default.
• W2003923132 hasConceptScore W2003923132C161573976 @default.
• W2003923132 hasConceptScore W2003923132C2776914184 @default.
• W2003923132 hasConceptScore W2003923132C2777391703 @default.
• W2003923132 hasConceptScore W2003923132C2777901630 @default.
• W2003923132 hasConceptScore W2003923132C2778764654 @default.
• W2003923132 hasConceptScore W2003923132C2779113265 @default.
• W2003923132 hasConceptScore W2003923132C2779306644 @default.
• W2003923132 hasConceptScore W2003923132C2780159080 @default.
• W2003923132 hasConceptScore W2003923132C2780609358 @default.
• W2003923132 hasConceptScore W2003923132C2780833929 @default.
• W2003923132 hasConceptScore W2003923132C3017594256 @default.
• W2003923132 hasConceptScore W2003923132C555293320 @default.
• W2003923132 hasConceptScore W2003923132C71924100 @default.
• W2003923132 hasIssue "12" @default.
• W2003923132 hasLocation W20039231321 @default.
• W2003923132 hasLocation W20039231322 @default.

• next